Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.

Adult volunteers received a booster dose (4 x 10(8) CFU) of attenuated Vibrio cholerae CVD 103-HgR oral vaccine 15 or 24 months after primary immunization. The immune response was modest, presumably due to rapid clearance of the vaccine strain by a primed immune system.

Podrobná bibliografie

Vydáno v:	Infect Immun
Hlavní autoři:	Cryz, S J, Levine, M M, Losonsky, G, Kaper, J B, Althaus, B
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1992
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC257409/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1500200/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.60.9.3916-3917.1992
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!